• Protagen Diagnostics

    The EORTC Brain Tumor Group and Protagen AG announce their collaboration to investigate the immuno-competence of long-term Glioblastoma survivors

  • Brain tumour

    Interim Results of the CATNON Study – the Effects of Temozolomide

  • Tackling brain tumours – EORTC proves value of academic collaboration in the research of brain cancer

  • brain

    EORTC helps improve standard of care for brain cancer patients

  • Wolfgang-Wick

    Combination of Bevacizumab and Lomustine with First Recurrence of Glioblastoma Prolongs PFS but not OS

  • Preusser_Matthias

    Enrollment of first patient in a Phase II trabectedin study in brain tumor type called meningioma

  • brain-scan-web

    Improving treatment for patients with recurrent glioblastoma

  • brain

    New research initiative to understand long-term survival with deadly brain cancer